Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation

计划入组 3,010 人 · 首次发布于 2023 年 7 月 21 日

Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Prolonged DAPT Regimen

计划入组 4,579 人 · 首次发布于 2017 年 1 月 18 日

Bioresorbable Polymer-Coated EES in Patients at High Bleeding Risk Undergoing PCI Followed by 1-Month DAPT

计划入组 1,023 人 · 首次发布于 2017 年 4 月 13 日

P2Y12 receptor antagonists

P2Y12 antagonists(Shanghai Hengrui Pharmaceuticals)

Ticagrelor(Brilinta, Brilique)

C₂₃H₂₈F₂N₆O₄S · Rx

Corvus Pharmaceuticals

United States

Kura Oncology

United States

Odyssey Therapeutics

CureGene Doses First Participant in U.S. Pivotal Trial of Evategrel, a Novel Dual-Formulation P2Y12 Inhibitor

P2Y12 Inhibitors Show 23% Reduction in Cardiovascular Events Compared to Aspirin in Post-Stent Patients

Concept Medical Initiates Global STARS DAPT Trial for Polymer-Free Drug-Eluting Stent in STEMI Patients